CD4 and sexually transmitted disease: Among the risk factors described in the literature for this progression are: advanced age, nulliparity, high-grade injury, oncogenic HPV serotypes, persistent HPV infection, HIV co-infection, recurrent cervical neoplasia, compromised margin status, reduced CD4 level, glandular extension, and presence of some associated sexually transmitted infections (STIs).(4,5,8-15)